NO20060475L - Rekombinant lubricinmolekyler og anvendelser derav - Google Patents

Rekombinant lubricinmolekyler og anvendelser derav

Info

Publication number: NO20060475L
Authority: NO; Norway
Prior art keywords: applications; recombinant lubricin; lubricin molecules; molecules; recombinant
Prior art date: 2003-08-14

Application number

NO20060475A

Other languages

English (en)

Norwegian (no)

Inventor

Lisa Anne Racie

Carl Ralph Flannery

Christopher John Corcoran

Bethany Annis Freeman

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-08-14

Filing date

2006-01-30

Publication date

2006-03-13

2006-01-30 Application filed by Wyeth Corp filed Critical Wyeth Corp

2006-03-13 Publication of NO20060475L publication Critical patent/NO20060475L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Immunology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Toxicology (AREA)
Physical Education & Sports Medicine (AREA)
Marine Sciences & Fisheries (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Neurosurgery (AREA)
Cardiology (AREA)
Pulmonology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

NO20060475A 2003-08-14 2006-01-30 Rekombinant lubricinmolekyler og anvendelser derav NO20060475L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US49574103P	2003-08-14	2003-08-14
PCT/US2004/026508 WO2005016130A2 (en)	2003-08-14	2004-08-13	Recombinant lubricin molecules and uses thereof

Publications (1)

Publication Number	Publication Date
NO20060475L true NO20060475L (no)	2006-03-13

Family

ID=34193342

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20060475A NO20060475L (no)	2003-08-14	2006-01-30	Rekombinant lubricinmolekyler og anvendelser derav

Country Status (21)

Country	Link
US (6)	US7642236B2 (zh)
EP (1)	EP1663291B1 (zh)
JP (1)	JP2007502122A (zh)
KR (1)	KR101078202B1 (zh)
CN (2)	CN102924584A (zh)
AU (2)	AU2004264970B2 (zh)
BR (1)	BRPI0413553A (zh)
CR (1)	CR8204A (zh)
DK (1)	DK1663291T3 (zh)
EC (1)	ECSP066364A (zh)
ES (1)	ES2388970T3 (zh)
HK (1)	HK1089110A1 (zh)
IL (2)	IL173258A (zh)
MX (1)	MXPA06001658A (zh)
NO (1)	NO20060475L (zh)
NZ (1)	NZ545021A (zh)
RU (2)	RU2376313C2 (zh)
SG (1)	SG145724A1 (zh)
UA (1)	UA91818C2 (zh)
WO (1)	WO2005016130A2 (zh)
ZA (1)	ZA200601291B (zh)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6743774B1 (en)	1999-04-23	2004-06-01	Rhode Island Hospital	Tribonectins
CA2575086A1 (en) *	2004-07-23	2006-02-02	Mucosal Therapeutics Llc	Compositions and methods for viscosupplementation
US20090068247A1 (en) *	2007-09-12	2009-03-12	Mucosal Therapeutics	Biocompatible devices coated with a tribonectin and methods for their production
US20090104148A1 (en) *	2007-09-18	2009-04-23	Jay Gregory D	Treatment and prevention of joint disease
US8506944B2 (en)	2008-05-07	2013-08-13	The Regents Of The University Of California	Replenishment and enrichment of ocular surface lubrication
SI2915529T1 (sl) *	2008-05-07	2017-09-29	The Regents Of The University Of California	Terapevtska regeneracija in obogatitev lubrikacije okularne površine
WO2010083239A2 (en)	2009-01-13	2010-07-22	Truitt Edward R Iii	Therapeutic modulation of vaginal epithelium boundary lubrication
CA2762989C (en)	2009-05-22	2021-04-13	Benjamin Sullivan	Prg4 for treatment of oral cavity boundary lubrication disorders
US11213566B2 (en)	2010-01-19	2022-01-04	Lubris Llc	Oral care compositions and methods
US8716204B2 (en)	2010-07-27	2014-05-06	Zimmer, Inc.	Synthetic synovial fluid compositions and methods for making the same
US20130116186A1 (en) *	2011-10-04	2013-05-09	Rhode Island Hospital, A Lifespan Partner	Lubricin injections to maintain cartilage health
WO2014115022A1 (en) *	2013-01-25	2014-07-31	Baylor College Of Medicine	A helper-dependent adenoviral gene therapy delivery and expression system
US20150010606A1 (en) *	2013-07-08	2015-01-08	Arthrex, Inc.	Intra-articular injection and implant attachment of molecule consisting of lubricin and extracellular superoxide dismutase or hyaluronic acid and extracellular superoxide dismutase
WO2015057993A1 (en) *	2013-10-16	2015-04-23	Ensisheim Partners Llc	Protein-specific formulations
WO2015060935A1 (en) *	2013-10-22	2015-04-30	Lubris, Llc	Control of rheological properties of mixed hyaluronate/lubricin solutions
JP6571101B2 (ja)	2013-11-26	2019-09-04	ルブリス，エルエルシー．	細胞間相互作用を阻害するための組成物及び方法
BR112017015310A8 (pt)	2015-01-26	2021-02-23	Lubris Llc	uso de pgr4 como um agente anti-inflamatório
DK3402530T3 (da)	2016-01-13	2020-11-23	Genzyme Corp	Rekombinante aav-vektorer, der udtrykker knoglebeskyttende gener, herunder has2 og lubricin, som er anvendelige til behandling af osteoarthritis og relaterede ledtilstande hos pattedyr
WO2017132376A1 (en)	2016-01-27	2017-08-03	Just Biotherapeutics, Inc.	Hybrid promoter and uses thereof
US20210260167A1 (en) *	2018-06-21	2021-08-26	Lubris Llc	Lubricin for use in wound healing
WO2020150390A1 (en) *	2019-01-15	2020-07-23	Cornell University	Recombinant mucins, and compositions and methods for using the same
MX2022010334A (es) *	2020-02-24	2022-09-19	Novartis Ag	Purificacion de polipeptidos producidos recombinantemente.
IT202000022636A1 (it)	2020-09-25	2022-03-25	Ente Ospedaliero Specializzato In Gastroenterologia Istituto Nazionale Di Ricovero E Cura A Caratter	“terapia di combinazione di sorafenib e/o regorafenib con la proteina ricombinante umana proteoglicano-4 per il trattamento dell'epatocarcinoma”

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2734862A (en) *		1956-02-14		Synthetic casein fiber elastic grease
US2487377A (en) *	1948-04-17	1949-11-08	Socony Vacuum Oil Co Inc	Lubricant
US2878184A (en) *	1953-12-29	1959-03-17	Rockwell Mfg Co	Hydrocarbon resistant glycerol base lubricant
AR207237A1 (es) *	1974-02-25	1976-09-22	Thomas A	Procedimiento para obtener extractos biologicos estables liofilizados solubles constituidos por complejos proteicos termorresistentes
US4438100A (en) *	1980-04-25	1984-03-20	A/S Orthana Kemisk Fabrik	Sterilized preserved, stable mucine-containing solutions
US5403592A (en) *	1987-08-25	1995-04-04	Macnaught Pty Limited	Lubricant composition for rheumatism
GB8803697D0 (en) *	1988-02-17	1988-03-16	Deltanine Research Ltd	Clinical developments using amniotic membrane cells
US5510418A (en) *	1988-11-21	1996-04-23	Collagen Corporation	Glycosaminoglycan-synthetic polymer conjugates
US5260417A (en) *	1989-04-03	1993-11-09	Genetics Institute, Inc.	Megakaryocyte growth promoting activity protein
US6433142B1 (en) *	1989-08-08	2002-08-13	Genetics Institute, Llc	Megakaryocyte stimulating factors
US5326558A (en) *	1989-08-08	1994-07-05	Genetics Institute, Inc.	Megakaryocytopoietic factor
AU652022B2 (en) *	1991-02-12	1994-08-11	C.R. Bard Inc.	Injectable medical device
US5605938A (en) *	1991-05-31	1997-02-25	Gliatech, Inc.	Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
CN1107891A (zh)	1994-03-04	1995-09-06	上海贝特生物技术有限公司	人促巨核细胞生成素及其分离纯化和基因克隆方法及应用
US5515590A (en) *	1994-07-19	1996-05-14	University Of Kentucky Research Foundation	Method for reducing the generation of wear particulates from an implant
US5709020A (en) *	1994-07-19	1998-01-20	University Of Kentucky Research Foundation	Method for reducing the generation of wear particulates from an implant
US5510122A (en) *	1994-09-28	1996-04-23	The Research Foundation Of State University Of New York	Preparation and use of whole saliva
US6743774B1 (en)	1999-04-23	2004-06-01	Rhode Island Hospital	Tribonectins
US6960562B2 (en) *	1999-04-23	2005-11-01	Rhode Island Hospital, A Lifespan Partner	Tribonectin polypeptides and uses thereof
US7001881B1 (en) *	1999-04-23	2006-02-21	Rhode Island Hospital	Tribonectins
AU6366100A (en) *	1999-07-23	2001-02-13	Case Western Reserve University	Novel methods and reagents for the treatment of osteoarthritis
WO2002062847A2 (en)	2000-12-29	2002-08-15	Glaxo Group Limited	Superficial zone protein and methods of making and using same
EP1440981A3 (en) *	2003-01-21	2005-11-23	Research Association for Biotechnology	Full-length human cdna

2004
- 2004-08-13 US US10/567,764 patent/US7642236B2/en not_active Expired - Fee Related
- 2004-08-13 NZ NZ545021A patent/NZ545021A/en not_active IP Right Cessation
- 2004-08-13 JP JP2006523436A patent/JP2007502122A/ja active Pending
- 2004-08-13 AU AU2004264970A patent/AU2004264970B2/en not_active Ceased
- 2004-08-13 MX MXPA06001658A patent/MXPA06001658A/es active IP Right Grant
- 2004-08-13 KR KR1020067003110A patent/KR101078202B1/ko not_active IP Right Cessation
- 2004-08-13 DK DK04781229.2T patent/DK1663291T3/da active
- 2004-08-13 UA UAA200602706A patent/UA91818C2/ru unknown
- 2004-08-13 ES ES04781229T patent/ES2388970T3/es not_active Expired - Lifetime
- 2004-08-13 SG SG200805896-8A patent/SG145724A1/en unknown
- 2004-08-13 BR BRPI0413553-9A patent/BRPI0413553A/pt not_active IP Right Cessation
- 2004-08-13 WO PCT/US2004/026508 patent/WO2005016130A2/en active Application Filing
- 2004-08-13 CN CN2012104146501A patent/CN102924584A/zh active Pending
- 2004-08-13 RU RU2006107925/13A patent/RU2376313C2/ru not_active IP Right Cessation
- 2004-08-13 EP EP04781229A patent/EP1663291B1/en not_active Expired - Lifetime
- 2004-08-13 CN CNA2004800299041A patent/CN1867350A/zh active Pending
2006
- 2006-01-19 CR CR8204A patent/CR8204A/es unknown
- 2006-01-19 IL IL173258A patent/IL173258A/en not_active IP Right Cessation
- 2006-01-30 NO NO20060475A patent/NO20060475L/no not_active Application Discontinuation
- 2006-02-13 ZA ZA200601291A patent/ZA200601291B/xx unknown
- 2006-02-14 EC EC2006006364A patent/ECSP066364A/es unknown
- 2006-10-10 HK HK06111118.8A patent/HK1089110A1/xx unknown
2009
- 2009-06-24 IL IL199528A patent/IL199528A/en not_active IP Right Cessation
- 2009-08-07 RU RU2009130434/10A patent/RU2009130434A/ru not_active Application Discontinuation
- 2009-11-19 US US12/622,141 patent/US7893029B2/en not_active Expired - Fee Related
- 2009-11-23 US US12/624,112 patent/US7897571B2/en not_active Expired - Fee Related
2010
- 2010-04-16 AU AU2010201537A patent/AU2010201537B2/en not_active Ceased
2011
- 2011-02-25 US US13/035,529 patent/US8420793B2/en not_active Expired - Fee Related
2013
- 2013-03-08 US US13/791,346 patent/US8987205B2/en not_active Expired - Fee Related
2015
- 2015-02-05 US US14/614,809 patent/US20150343019A1/en not_active Abandoned

Also Published As

Publication number	Publication date
JP2007502122A (ja)	2007-02-08
WO2005016130A2 (en)	2005-02-24
US20150343019A1 (en)	2015-12-03
US7893029B2 (en)	2011-02-22
CR8204A (es)	2007-10-01
DK1663291T3 (da)	2012-07-02
AU2010201537B2 (en)	2012-02-23
US8987205B2 (en)	2015-03-24
ES2388970T3 (es)	2012-10-22
UA91818C2 (ru)	2010-09-10
AU2004264970B2 (en)	2010-02-11
IL199528A (en)	2013-03-24
US7897571B2 (en)	2011-03-01
US20070191268A1 (en)	2007-08-16
MXPA06001658A (es)	2006-04-28
KR101078202B1 (ko)	2011-11-01
NZ545021A (en)	2009-03-31
KR20060072124A (ko)	2006-06-27
HK1089110A1 (en)	2006-11-24
RU2006107925A (ru)	2006-07-27
EP1663291A4 (en)	2009-08-05
AU2004264970A1 (en)	2005-02-24
AU2010201537A1 (en)	2010-05-06
RU2009130434A (ru)	2011-02-20
IL199528A0 (en)	2011-08-01
EP1663291A2 (en)	2006-06-07
BRPI0413553A (pt)	2006-10-17
EP1663291B1 (en)	2012-06-06
SG145724A1 (en)	2008-09-29
IL173258A0 (en)	2006-06-11
ECSP066364A (es)	2006-08-30
RU2376313C2 (ru)	2009-12-20
US8420793B2 (en)	2013-04-16
US20110189731A1 (en)	2011-08-04
ZA200601291B (en)	2010-08-25
US20130196930A1 (en)	2013-08-01
US20100080848A1 (en)	2010-04-01
IL173258A (en)	2010-12-30
US7642236B2 (en)	2010-01-05
WO2005016130A3 (en)	2006-02-02
CN1867350A (zh)	2006-11-22
CN102924584A (zh)	2013-02-13
US20100074935A1 (en)	2010-03-25

Publication	Publication Date	Title
NO20060475L (no)	2006-03-13	Rekombinant lubricinmolekyler og anvendelser derav
ES2621211T3 (es)	2017-07-03	Composiciones inmunogénicas que comprenden polipéptidos de mycobacterium tuberculosis y fusiones de los mismos
NO20050380L (no)	2005-07-25	System og fremgangsmate for a anvende nanoskala fyllmateriale i nedhulls applikasjoner
GB2447383A (en)	2008-09-10	All electric subsea boosting system
AR059667A1 (es)	2008-04-23	Montaje de desgaste
NO20073293L (no)	2007-08-17	Toll-liknende reseptor-3-antagonister, fremgangsmater og anvendelser
NO20080023L (no)	2008-03-05	Magnetoreologisk vaeske
NO20080246L (no)	2008-03-17	Anti-IGF1R-antistofformuleringer
CR20110245A (es)	2011-08-29	Mutantes fgf21 y uso de los mismos.
AR062069A1 (es)	2008-10-15	Replegado de proteinas recombinantes
ATE485802T1 (de)	2010-11-15	Multidosis-phiolenanordnungen und adapter dafür
EP1690356A4 (en)	2013-12-25	802.1X AUTHENTICATION TECHNIQUE FOR SHARED SUPPORT
BR0116904A (pt)	2004-02-10	Composição e método para inibição da formação de hidratos de gases
BRPI0600504A (pt)	2007-04-27	conjunto de válvula para uma bomba usada para bombear fluido abrasivo
AR067033A1 (es)	2009-09-30	Recuperacion de hidrocarburos y de combustibles fosiles basada microondas
BRPI0617788A2 (pt)	2009-12-01	processos isolados estaticamente verificáveis com comunicação interprocessos
SG170124A1 (en)	2011-04-29	Razors
ATE501234T1 (de)	2011-03-15	Pyrolysesystem
BR112014016815A8 (pt)	2017-07-04	conjunto de ventilação de fabricação de compósito e modo de conexão
AR061212A1 (es)	2008-08-13	Un sistema adhesivo
BRPI0511802A (pt)	2008-01-15	processo para criação de meios para uso em separadores de ar/óleo
BRPI0409590A (pt)	2006-05-02	arruela de vedação, e, métodos para formar uma vedação circunferencial e para selar um espaço entre um parafuso e uma superfìcie plana
UY25357A1 (es)	2000-12-29	Nuevos pentasacáridos, procedimiento para su preparación y composiciones farmacéuticas que los contienen.
BR112015003995A2 (pt)	2017-07-04	lóbulos assimétricos para motores e bombas
DE502007000285D1 (de)	2009-01-22	Türkonstruktion für einen Aufzug

Legal Events

Date	Code	Title	Description
2014-03-24	FC2A	Withdrawal, rejection or dismissal of laid open patent application